Jane Street Group, LLC Aspira Women'S Health Inc. Transaction History

Jane Street Group, LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 14, 2023	BUY	$0.3 - $0.41 $3,908 - $5,341	13,027 New	13,027 $4,000
Q1 2022 May 17, 2022	SELL	$0.88 - $1.81 $15,504 - $31,890	-17,619 Closed	0 $0
Q4 2021 Feb 15, 2022	BUY	$1.63 - $3.43 $28,718 - $60,433	17,619 New	17,619 $31,000
Q3 2021 Nov 16, 2021	SELL	$3.19 - $5.48 $59,640 - $102,454	-18,696 Closed	0 $0
Q2 2021 Aug 16, 2021	BUY	$4.78 - $6.84 $89,366 - $127,880	18,696 New	18,696 $105,000
Q3 2020 Nov 17, 2020	SELL	$2.54 - $4.56 $216,900 - $389,396	-85,394 Closed	0 $0
Q2 2020 Aug 17, 2020	BUY	$0.78 - $5.25 $66,607 - $448,318	85,394 New	85,394 $328,000

431K

Ticker AWH
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 124,296,000
Market Cap $123M
Description
Aspira Women's Health Inc., together with its subsidiaries, engages in developing and commercializing diagnostic tests for gynecologic disease in the United States. The company provides OVA1, OVERA, and OVA1plus to detect risk of ovarian malignancy in women with adnexal masses. It also offers ASPiRA GenetiX, a genetic test for the risk of gyneco...

Get notified when there are updates to the investment portfolio of Jane Street Group, LLC, based on Form 13F filings with the SEC.

Stay updated on Jane Street Group, LLC with notifications on news.